2007 Leads Pharmaceutical research 
PM360
NOVEMBER 12, 2024
One in three people is expected to develop a neurological condition in their lifetime, and neurological diseases are the leading cause of disability. Before Sage, he served as president of Alnylam Pharmaceuticals, Inc. since 2007, and he previously held the position of chief operating officer when he first joined the company in 2003.
Pharmaceutical Technology
SEPTEMBER 10, 2008
NC: A few projects focusing on influenza, which Biotest was involved with, concluded in 2007. It will most probably lead to a new anti-flu vaccine. Pharmaceutical research generally, and pre-clinical research in particular, is very dynamic in its development. Can you reveal the results of these?
Expert insights. Personalized for you.
52 
Let's personalize your content